Relationship between pre-bronchodilator FEV1 and ex-vivo intrinsic tone in human small airways

F. Sanai (Sydney, Australia), A. Cairncross (Perth, Australia), P. Noble (Perth, Australia), J. Elliot (Perth, Australia), A. James (Perth, Australia), G. King (Sydney, Australia), B. Mcparland (Sydney, Australia)

Source: International Congress 2019 – Advances in COPD pharmacology
Session: Advances in COPD pharmacology
Session type: Poster Discussion
Number: 2037
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Sanai (Sydney, Australia), A. Cairncross (Perth, Australia), P. Noble (Perth, Australia), J. Elliot (Perth, Australia), A. James (Perth, Australia), G. King (Sydney, Australia), B. Mcparland (Sydney, Australia). Relationship between pre-bronchodilator FEV1 and ex-vivo intrinsic tone in human small airways. 2037

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Relationship between FEV1 and PEF in patients with airways obstruction
Source: Eur Respir J 2004; 24: Suppl. 48, 120s
Year: 2004

Post-bronchodilator changes in volumes and airway caliber according to Peak flow and FEV1 reversibility
Source: International Congress 2019 – New developments in sleep-disordered breathing, gas exchange and lung function in children
Year: 2019

FEV6 and FEV1/FEV6 have higher association with small airway function and oxygen saturation than FVC and FEV1/FVC in patients with asthma.
Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers
Year: 2020

Comparison of bronchodilatator response of FEV1 and airway resistance
Source: Annual Congress 2003 - Assessing airway function: practicalities and clinical applications
Year: 2003


Using the pre-bronchodilator spirometry curvature to improve estimation of post-bronchodilator airflow obstruction
Source: International Congress 2019 – Physiologic assessment of airway diseases
Year: 2019


FEV6 as a surrogate for FVC in detecting airways obstruction and restriction in the workplace
Source: Eur Respir J 2006; 27: 374-377
Year: 2006



The ratio of inspiratory ΣRrs to expiratory ΣRrs measured by forced oscillation technique correlates with the parameters reflecting narrowing of small airway measured by spirometry in patients with mild to moderate COPD
Source: Annual Congress 2013 –New issues in lung function testing
Year: 2013

Auscultatory forced expiratory time as a predictor of FEV1 and as a clinical test of airway obstruction
Source: Eur Respir J 2004; 24: Suppl. 48, 225s
Year: 2004

Maximally attained level of FEV1 and FEV1 decline determine airway hyperresponsiveness in adults
Source: Eur Respir J 2003; 22: Suppl. 45, 17s
Year: 2003

Comparison of FEV1 and specific airway conductance in assessing bronchial response to occupational agents
Source: Eur Respir J 2003; 22: Suppl. 45, 488s
Year: 2003

Comparison of sensitivity and variability of sGaw and FEV1 for measuring bronchodilation in healthy and asthmatic subjects
Source: Eur Respir J 2004; 24: Suppl. 48, 338s
Year: 2004

FEV6 as an alternative for FVC in predicting airway obstruction
Source: Eur Respir J 2006; 28: Suppl. 50, 220s
Year: 2006

Comparison of FEV1 and mid flow parameters as markers of bronchial hyper responsiveness to methacholine
Source: Eur Respir J 2003; 22: Suppl. 45, 276s
Year: 2003

Can the prediction point for FEV1 / FVC be determined in patients with insufficient expiratory maneuver to determine airflow obstruction?
Source: Virtual Congress 2020 – Advances in lung function testing
Year: 2020


Forced expiratory tracheal noise time in diagnostics of hidden bronchial obstruction among spirometry negative asthma patients
Source: Annual Congress 2011 - Lung function today and tomorrow I
Year: 2011

Why should we perform lung function tests?
Source: Annual Congress 2007 - PG17 - Lung function measurement in the community
Year: 2007



Exploring the clinical utility of measuring reversibility in mid expiratory flow and its relationship with FEV1 reversibility in patients with asthma.
Source: International Congress 2017 – Biomarker-based asthma control
Year: 2017

The effect of nebulised MgSO4 on lung function in stable severe asthma patients with persistent airflow limitation
Source: Annual Congress 2007 - New drugs for asthma
Year: 2007




How to interpret reduced forced expiratory volume in 1 s (FEV1)/vital capacity ratio with normal FEV1
Source: Eur Respir J 2009; 33: 1396-1402
Year: 2009



Spirometry forced expiratory time is driven by central airway obstruction in asthmatic children
Source: Virtual Congress 2021 – Best of paediatric physiology and sleep research
Year: 2021